MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Altered levels of interleukin-6 in Parkinson’s disease patients with and without Covid-19

    R. Matmurodov, B. Muminov, K. Khalimova (Tashkent, Uzbekistan)

    Objective: Comparison of serum IL-6 levels in Parkinson's disease (PD) patients with and without Сovid-19. Background: Scientists say that the infectious agent SARS-CoV-2 increases the…
  • 2024 International Congress

    Comparison of Monopolar and Bipolar Sensing of Beta Frequency in Parkinson’s Disease of the Subthalamic Nucleus for Deep Brain Stimulation

    D. Kern, E. Radcliffe, S. Ojemann, D. Kramer, M. Case, C. Zarns, A. Holt-Becker, R. Raike, A. Baumgartner, J. Thompson (AURORA, USA)

    Objective: To compare bipolar sensing (BS) with monopolar sensing (MS) of local field potentials (LFP) within the beta band of subthalamic nucleus (STN) in Parkinson’s…
  • 2024 International Congress

    Do Proton Pump Inhibitors Increase the Risk of Parkinson’s Disease? A systematic review and meta-analysis

    S. Karki, A. Parajuli (Kathmandu, Nepal)

    Objective: To provide an updated meta-analysis of the observational studies examining the association between proton pump use and Parkinson’s disease. Background: The exact cause of…
  • 2024 International Congress

    www.PregSpark.com, introducing the International PregnancieS and Parkinson’s Registry

    A. Oosterbaan, M. Kapelle, H. Bogers, L. Vos, B. Bloem, M. Meinders, B. Post (Nijmegen, Netherlands)

    Objective: To introduce the International PregnancieS and Parkinson’s Registry (www.PregSpark.com). Background: Pregnancy in Parkinson’s disease (PD) is rare, but with PD being the fastest growing…
  • 2024 International Congress

    Effects of Osteopathic Manipulative Treatment (OMT) on Lower Extremity Muscle Characteristics in Parkinson’s Disease (PD) Patients

    R. Radigan, A. Finkelstein, M. Mehra, P. Bhushan, T. Lombardo, S. Yao (Old Westbury, USA)

    Objective: To define the mechanism of Osteopathic Manipulative Treatment (OMT) in decreasing symptomology and improving gait in Parkinson’s Disease (PD) patients. Background: A key symptom…
  • 2024 International Congress

    Selective subthalamic DBS improved non-motor disorders without affecting weight gain in parkinsonism

    H. Tibar, K A. Charles, F. Naudet, PH. De-Deurwaerdère, A. Benazzouz (Rabat, Morocco)

    Objective: Evaluate the impact of subthalamic nucleus deep brain stimulation (STN-DBS) on weight gain in Parkinsonian rats: The primary objective would be to determine whether…
  • 2024 International Congress

    Lower plasma piperine levels in Parkinson’s disease: a PPMI metabolomics analysis

    N. Xia, J. Ripping, R. Bakshi, E. Macklin, S. Molsberry, X. Chen, A. Ascherio, M. Schwarzschild (Charlestown, USA)

    Objective: To explore piperine as a potential biomarker for Parkinson’s disease (PD) among GBA and LRRK2 mutation carriers and non-carriers. Background: Piperine is a yellow…
  • 2024 International Congress

    Characteristics of Language Abnormalities in Multiple System Atrophy and Parkinson’s Disease

    M. Subert, M. Novotny, P. Dusek, J. Klempir, J. Rusz, T. Tykalova (Prague, Czech Republic)

    Objective: We characterized complex language profile and explore diagnostic potential of automated language analysis of natural spontaneous speech in differentiation between multiple system atrophy (MSA)…
  • 2024 International Congress

    Progression of motor asymmetry in the MDS-UPDRS III in Parkinson’s Disease with and without REM Sleep Behavior Disorder over five years

    S. Elasfar, H. Hameed, K. Ehgoetz-Martens (Waterloo, Canada)

    Objective: To compare progression of motor asymmetry using the MDS-UPDRS-III in Parkinson’s Disease (PD) with and without probable REM Sleep Behavior disorder (pRBD) over 5…
  • 2024 International Congress

    Association between Kinetic Parameters of Alpha-synuclein Seed Amplification Assay in CSF and Parkinson’s Disease Subtypes.

    P. Grillo, G. Riboldi, A. Pisani, L. Concha, U. Kang (New York City, USA)

    Objective: To assess differences in kinetics parameters of the αSyn seeding amplification assays in CSF (CSF-αSyn-SAA) in Parkinson’s Disease (PD) subtypes based on the presence…
  • « Previous Page
  • 1
  • …
  • 176
  • 177
  • 178
  • 179
  • 180
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley